20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding Poloxamer 407: Properties, Applications, and Sourcing Best Practices

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing comprehensive insights into key pharmaceutical excipients. Poloxamer 407, a well-established non-ionic surfactant and triblock copolymer, is a compound of significant interest due to its multifaceted utility in pharmaceutical formulations.

The fundamental poloxamer 407 API properties are derived from its unique molecular structure, consisting of a central hydrophobic polypropylene glycol block flanked by two hydrophilic polyethylene glycol blocks. This amphiphilic nature underpins its effectiveness as a solubilizer, emulsifier, and stabilizer. Its physical state is typically a white or off-white solid powder, with a characteristic melting point contributing to its thermoreversible gelation capabilities.

The extensive poloxamer 407 uses in medicine span a wide array of applications. As a poloxamer 407 solubilization agent, it is critical for improving the bioavailability of poorly soluble drugs, a common hurdle in drug development. Furthermore, its ability to form thermoreversible gels is exploited in controlled-release systems, making it a valuable component for sustained drug delivery. The poloxamer 407 thermoreversible gel aspect is particularly advantageous for applications requiring temperature-sensitive drug release.

For pharmaceutical manufacturers, sourcing high-quality Poloxamer 407 is paramount. NINGBO INNO PHARMCHEM CO.,LTD. emphasizes the importance of supplier quality assurance, ensuring that the material meets stringent pharmacopeial standards (e.g., USP-NF, EP). When you buy Poloxamer 407 for pharma, prioritizing a supplier with robust quality control and a transparent supply chain is essential for product consistency and regulatory compliance.

Understanding the nuanced poloxamer 407 formulation benefits allows formulators to optimize their products. Whether it's enhancing the stability of a suspension or enabling a novel delivery mechanism, Poloxamer 407 offers a flexible and effective solution. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting these formulation efforts by providing premium-grade Poloxamer 407.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Poloxamer 407: A Versatile Excipient for Topical and Oral Drug Delivery Systems

Next: Innovating with Poloxamer 407: From Excipient to Enabling Technology in Pharmaceuticals

All Rights Reserved